← All trials
NCT06949059
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2025
- Primary completion
- Dec 31, 2026
- Completion date
- Dec 31, 2027
- First posted
- Apr 29, 2025
- Last posted
- Nov 17, 2025
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Nanjing UniversityLead sponsor
- Nanjing UniversitySponsor investigator
- Yichang Humanwell Pharmaceutical Co.,LtdCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.